Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.

Source:http://linkedlifedata.com/resource/pubmed/id/2969766

Brain Res. 1988 Jun 21 453 1-2 393-6

Download in:

View as

General Info

PMID
2969766